X4 Pharmaceuticals, Inc. (XFOR) Total Assets by Year
X4 Pharmaceuticals, Inc. closed fiscal year 2025 with $290.5M in total assets, $104.2M in total liabilities and $186.3M in shareholder equity. This represents an increase of 98.3% from the prior fiscal year. The table below carries 10 fiscal years, from 2016 to 2025, and the quarters X4 Pharmaceuticals, Inc. has filed alongside them.
Annual figures, oldest first. Point at a bar to read its period.
XFOR Balance Sheet by Fiscal Year
Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.
| Metric | FY2510-K | FY2410-K | FY2310-K | FY2210-K | FY2110-K | FY2010-K | FY1910-K | FY1810-K | FY1710-K | FY1610-K |
|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | $290.5M+98.3% | $146.4M-0.6% | $147.3M-5.4% | $155.6M+32.8% | $117.2M-4.6% | $122.9M-23.5% | $160.7M+1516.0% | $9.9M-87.8% | $81.3M | N/A |
| Total Liabilities | $104.2M-16.2% | $124.3M+29.3% | $96.2M+17.9% | $81.5M+54.5% | $52.8M+5.4% | $50.1M+59.1% | $31.5M-63.8% | $87.0M-30.8% | $125.8M | N/A |
| Total Equity | $186.3M+741.1% | $22.1M-56.7% | $51.1M-31.0% | $74.1M+15.0% | $64.4M-11.5% | $72.8M-43.7% | $129.2M+267.6% | -$77.1M-73.1% | -$44.5M-93.2% | -$23.1M |
XFOR Balance Sheet by Quarter
Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q | Q2'2410-Q | Q1'2410-Q | Q4'2310-K | Q3'2310-Q |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | $253.1M+140.6% | $270.3M+107.9% | $290.5M+98.3% | $163.6M-8.2% | $105.2M-50.1% | $130.0M+15.9% | $146.4M-0.6% | $178.2M+2.8% | $210.6M+21.5% | $112.2M-9.8% | $147.3M-5.4% | $173.3M+52.8% |
| Total Liabilities | $97.6M-3.5% | $101.8M-4.9% | $104.2M-16.2% | $101.9M-14.0% | $101.2M-12.9% | $107.1M-3.7% | $124.3M+29.3% | $118.5M+12.2% | $116.2M+9.7% | $111.1M+52.8% | $96.2M+17.9% | $105.7M+105.0% |
| Total Equity | $155.5M+3814.7% | $168.4M+634.2% | $186.3M+741.1% | $61.6M+3.4% | $4.0M-95.8% | $22.9M+2114.7% | $22.1M-56.7% | $59.6M-11.8% | $94.5M+39.9% | $1.0M-98.0% | $51.1M-31.0% | $67.6M+9.3% |
What total assets means
Total assets is everything the company owns on the balance sheet date, total liabilities is everything it owes, and the difference between them is the equity that belongs to shareholders.
More X4 Pharmaceuticals, Inc. financials
Frequently Asked Questions
What was X4 Pharmaceuticals, Inc.'s total assets in fiscal year 2025?
X4 Pharmaceuticals, Inc. closed fiscal year 2025 with $290.5M in total assets, $104.2M in total liabilities and $186.3M in shareholder equity.
How fast is X4 Pharmaceuticals, Inc.'s total assets growing?
X4 Pharmaceuticals, Inc. (XFOR) total assets rose by 98.3% year over year, from $146.4M to $290.5M in fiscal year 2025.
What was X4 Pharmaceuticals, Inc.'s total assets in the most recent quarter?
X4 Pharmaceuticals, Inc. (XFOR) reported $253.1M in total assets in Q2 2026. This represents an increase of 140.6% from the same quarter a year earlier.
What does total assets mean on a financial statement?
Total assets is everything the company owns on the balance sheet date, total liabilities is everything it owes, and the difference between them is the equity that belongs to shareholders. This page lists what X4 Pharmaceuticals, Inc. (XFOR) reported on that line in every period on record.